Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery

Autor: Cristina Álvarez-Escolá, Beatriz Pelegrina, Angel Sanz‐Valtierra, Jersy Cardenas-Salas, Beatriz Lecumberri

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Clinical Case Reports

Key Clinical Message Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be rul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::432ae08473dc90238f1b38ebfa20f770
https://hdl.handle.net/20.500.12530/20071